Arbutus (ABUS) Up in Active Trading for June 23

Equities Staff  |

Shares of Arbutus Biopharma Corp (NASDAQ:ABUS) traded 6.57% higher on June 23 to close at $2.92.

1,221,519 were traded today. Their current average 30 day volume is 989,781 shares.

Arbutus lost 29.56% year-to-date in 2022.

The company expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on Arbutus visit the company profile.

About Arbutus Biopharma Corp

Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).

To get more information on Arbutus Biopharma Corp and to follow the company's latest updates, you can visit the company's profile page here: Arbutus Biopharma Corp's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content